[OK-432与重组白细胞介素-2联合癌症免疫疗法的基础研究——通过静脉注射OK-432诱导小鼠脾脏中淋巴因子激活的杀伤（LAK）前体细胞] - Suppr

[A basic study of combination cancer immunotherapy with OK-432 and rIL-2--induction of lymphokine-activated killer (LAK) precursor cells in murine spleen by intravenous administration of OK-432].

Shimoda K, Saito T, Kobayashi M

Nihon Gan Chiryo Gakkai Shi. 1988 Jul 20;23(7):1566-73.

Abstract

摘要

Nihon Gan Chiryo Gakkai Shi. 1988 Jul 20;23(7):1566-73.

Biotherapy. 1992;5(1):63-9. doi: 10.1007/BF02194786.

Anticancer Res. 1990 Mar-Apr;10(2A):441-6.

J Biol Response Mod. 1990 Feb;9(1):53-60.

Hepatogastroenterology. 1994 Aug;41(4):363-6.

Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 2):1290-7.

Cancer Res. 1986 Oct;46(10):4973-8.

Jpn J Exp Med. 1987 Jun;57(3):183-8.

Nat Immun Cell Growth Regul. 1990;9(4):283-96.

Cancer Res. 1985 Aug;45(8):3735-41.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。